Pimozide Terminated Phase 3 Trials for Depression / Psychosomatic Disorders / Schizophrenia / Dementia / Anxiety Disorders Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02374567Pharmacovigilance in Gerontopsychiatric Patients